𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modulation of intestinal and liver fatty acid-binding proteins in Caco-2 cells by lipids, hormones and cytokines

✍ Scribed by Nadia Dubé; Edgard Delvin; Wagner Yotov; Carole Garofalo; Moise Bendayan; Jacques H. Veerkamp; Dr. Emile Levy


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
236 KB
Volume
81
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Intestinal and liver fatty acid binding proteins (I‐ and L‐FABP) are thought to play a role in enterocyte fatty acid (FA) trafficking. Their modulation by cell differentiation and various potential effectors was investigated in the human Caco‐2 cell line. With the acquisition of enterocytic features, Caco‐2 cells seeded on plastic progressively increased L‐FABP quantities, whereas I‐FABP was not detectable even very late in the maturation process. On permeable filters that improved differentiation markers (sucrase, alkaline phosphatase, transepithelial resistance), Caco‐2 cells furthered their L‐FABP content and expressed I‐FABP. Western blot analysis showed a significant increase in I‐ and L‐FABP expression following an 8‐hour incubation period with butyric acid, oleic acid, and phosphatidylcholine. However, in all cases, I‐FABP levels were higher than L‐FABP concentrations regardless of the lipid substrates added. Similarly, hydrocortisone and insulin enhanced the cellular content of I‐ and L‐FABP whereas leptin triggered I‐FABP expression only after an 8‐hour incubation. Finally, tumor necrosis factor‐α was more effective in increasing the cytosolic amount of I‐FABP levels. In conclusion, our data demonstrate that I‐FABP expression is limited to fully differentiated Caco‐2 cells and can be more easily regulated than L‐FABP by lipids, hormones, and cytokines. J. Cell. Biochem. 81: 613–620, 2001. © 2001 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Modulation of apo A-IV transcript levels
✍ Simona Stan; Edgard E. Delvin; Ernest Seidman; Thérèse Rouleau; Armin Steinmetz; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

It has been postulated that apolipoprotein (apo) A-IV plays various significant roles in lipid transport and lipoprotein metabolism. Although it is controlled by fat feeding, so far little else is known about its regulation by specific fatty acids. In this study, we focused on the modulation of apo

Down-regulation of insulin-like growth f
✍ Dae-Ghon Kim; Dae-yeol Lee; Baik-Hwan Cho; Kyung-Ran You; Mi-Young Kim; Deuk-Soo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB 👁 1 views

We observed that all-trans-retinoic acid (RA) down-regulated insulin-like growth factor binding proteins (IGFBPs) in cultured human hepatoma cells (Hep 3B, PLC/PRF/5, and Hep G2); therefore, we characterized the role of this down-regulation in cell growth. Treatment with 10 micromol/L RA revealed a

Sodium arsenite downregulates transcript
✍ Dan D. Hershko; Bruce W. Robb; Guang-jo Luo; Eric S. Hungness; Per-Olof Hasselgr 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB 👁 1 views

## Abstract In recent studies, sodium arsenite (SA) inhibited IL‐6 production in cultured intestinal epithelial cells, at least in part by downregulating the activity of nuclear factor‐kappaB (NF‐κB). The influence of SA on the activity of other transcription factors regulating the interleukin‐6 (_

Modulation of the estrogen-regulated pro
✍ Simone Panagiotou; Anastassia Hatzoglou; Fabien Calvo; Pierre-Marie Martin; Elia 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 3 views

In many cancer cell lines, including breast, prostate, lung, brain, head and neck, retina, and the gastrointestinal tract, opioids decrease cell proliferation in a dose-dependent and reversible manner. Opioid and/or other neuropeptide receptors mediate this decrease. We report that only the steroid-